General
Laponite was obtained from Laporte Adsorbents. Bis(oxazoline) ligand 1a was prepared by condensation of (S)-phenylglycinol with dimethylmalononitrile. 1, 2 Azabis(oxazoline) ligand 2a was prepared from (S)-2-amino-4-phenyl-4,5-dihydro-1,3-oxazole and (S)-2-ethoxy-4-phenyl-4,5-dihydro-1,3-oxazole. 3 Azabis(oxazoline) ligands 2b and 2c were prepared from (S)-2-amino-4-tert-butyl-4,5-dihydro-1,3-oxazole and (S)-2-amino-4-isopropyl-4,5-dihydro-1,3-oxazole respectively. 2, 4 Methyl phenyldiazoacetate was prepared by reaction of methyl phenylacetate with p-acetamidobenzenesulfonylazide. Preparation of laponite-immobilized catalysts: 6 Laponite (1 g) was dried under vacuum for 24 h prior to use. The chiral ligand (0.37 mmol) and Cu(OTf) 2 (115.7 mg, 0.32 mmol) were dissolved in the minimum required amount of anhydrous dichloromethane under argon atmosphere, the solution was stirred for 15 min and filtered through a PTFE microfilter. The solvent was eliminated under vacuum, the complex was re-dissolved in methanol (5.5 mL), laponite was added and the suspension was stirred for 24 h at room temperature. The solid was filtered off, washed with methanol (14 ml) and dichloromethane (20 ml), and finally dried under vacuum for 24 h. Catalysts were characterized by copper analysis (plasma emission spectroscopy on a Perkin-Elmer Plasma 40 emission spectrometer), elemental analysis (PerkinElmer 2400 elemental analyzer), X ray diffraction of oriented (D-max Rigaku system with rotating anode), and transmission FTIR (self-supported wafers evacuated at < 10 -4 Torr and 50°C in a Nicolet Avatar 360 spectrometer). 
Catalytic tests

Homogeneous insertion reaction
The catalyst was prepared with the corresponding ligand (0.025 mmol) and Cu(OTf) 2 (0.02 mmol) in anhydrous CH 2 Cl 2 (0.5 mL) under an inert atmosphere. The mixture was stirred for 30 min, the solution was microfiltered and the solvent removed under an inert gas stream.
This complex was dissolved in anhydrous substrate (THF, THP, 1, 1, or diisopropylether, 10 mL), n-decane (100 mg) was added as an internal standard and the solution heated under reflux. A solution of methyl phenyldiazoacetate (1 mmol) in anhydrous substrate (10 mL) was slowly added during 2 h with a syringe pump. Once the addition had finished, the reaction mixture was stirred and heated under reflux for 30 min. The yield and diastereoselectivity were determined by GC.
Heterogeneous insertion reactions
A suspension of dried heterogeneous catalyst (100 mg) in anhydrous substrate (10 mL) with n-decane (100 mg) as internal standard was heated under reflux under an inert atmosphere. A solution of methyl phenyldiazoacetate (1 mmol) in anhydrous substrate (10 mL)
was slowly added during 2 h with a syringe pump.
Once the addition had finished, the reaction mixture was stirred and heated under reflux for 30 min. The catalyst was filtered off and washed with substrate (5 mL). The yield and diastereoselectivity were determined by GC. The catalyst was dried under vacuum and reused under the same conditions. Alternatively, the catalyst was suspended in a mixture of THF (2 mmol) and n-decane (10 mg) in anhydrous hexane (10 mL). The suspension was heated under reflux under an inert atmosphere and a solution of methyl phenyldiazoacetate (1 mmol) in anhydrous hexane (10 mL) was slowly added during 2 h with a syringe pump. The reaction was then treated and analyzed as described above.
Isotopic effect
The catalyst was added to a solution of THF (2 mmol Methyl (2R*,S*)--(oxolan-2-yl)phenylacetate (unlike isomers, 7, 135.3, 128.9, 128.7, 127.8, 75 Methyl (2R*,S*)--(1,4-dioxan-2-yl)phenylacetate (unlike isomers, 8): Methyl - (1,3-dioxolan-2-yl) 
THF
The crude was purified by column chromatography on silica gel using n-hexane/diethyl ether (7/3) as an eluent, allowing isolation of 3 and a mixture 3+4. Two semi-preparative HPLC resolutions were carried out using a a 250 × 20 mm ID Chiralpak® IB column and a mixture nhexane/2-propanol (99.5/0.5) as mobile phase at a flow rate of 16 mL/min. 130 mg of racemic 3
were dissolved in 1.4 mL of n-hexane/2-propanol (99.5/0.5) and introduced into the column by successive injections of 0.1 mL (every 30 minutes). Three separate fractions were collected. 3S
(38 mg) and 3R (36 mg) were obtained in enantiopure form in fractions 1 and 3 respectively.
The mixture of stereoisomers 3+4 (400 mg) was dissolved in 2 mL of the same mixture of solvents and introduced into the column by successive injections of 0.1 mL (every 30 min).
Seven fractions were collected, and both enantiomers of 4 were obtained from the fifth (20 mg) and seventh (10 mg) fractions. Second eluted like enantiomer 4: +18.6 (c 0.7, CHCl 3 ).
THP
The crude was purified by column chromatography on silica gel using n-hexane/ethyl acetate (9/1) as an eluent, allowing isolation of 5 and a mixture 5+6. Two semi-preparative HPLC resolutions were carried out using a 250 × 20 mm ID Chiralpak® IA column and a mixture n-hexane/ethanol (99.8/0.2) as mobile phase at a flow rate of 16 mL/min. 90 mg of racemic 5
were dissolved in 0.9 mL of n-hexane/ethanol (1/1) and introduced into the column by successive injections of 0.1 mL (every 12 minutes). Three separate fractions were collected. 5S
(20 mg) and 5R (30 mg) (tentatively assigned) were obtained in enantiopure form in fractions 1 and 3 respectively. The mixture of stereoisomers 5+6 (70 mg) was dissolved in 1.5 mL of nhexane/ethanol (1/1) and introduced into the column by successive injections of 0.1 mL (every 32 minutes). Seven fractions were collected but it was not possible to separate both enantiomers of 6. Only in the seventh fraction 5 mg of a 5/95 mixture of both enantiomers were obtained.
(2R,S)-5S: −76.4 (c 0.55, CCl 4 ).
(2S,R)-5R: +78.2 (c 0.75, CCl 4 ).
